Drug Type Biological products |
Synonyms |
Target |
Mechanism properdin inhibitors(complement factor properdin inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Geographic Atrophy | Phase 2 | - | 25 Sep 2015 | |
Age Related Macular Degeneration | Phase 2 | - | 01 May 2013 | |
Dystrophy, Macular | Phase 2 | - | - | |
Geographic Atrophy | Discovery | - | 25 Sep 2015 | |
Dystrophy, Macular | Discovery | - | - |
Phase 2 | 114 | (CLG561) | wddhhhjybr(oureenclhf) = umwowywlmo fuojvyxhuu (svrmmkbuav, iliibsbpeq - bfdlnfceoh) View more | - | 19 Dec 2018 | ||
wddhhhjybr(oureenclhf) = fweqnzxmow fuojvyxhuu (svrmmkbuav, cryqdxemug - ntvdsaymzr) View more | |||||||
Phase 2 | - | xkcvcvwmcj(btmpklhzid) = iglkpsytlo nessdgbyvg (mqekvqhpua ) View more | - | 01 May 2016 |